A citation-based method for searching scientific literature

Ole Vincent Ancker, Marcus Krüger, Markus Wehland, Manfred Infanger, Daniela Grimm. Int J Mol Sci 2019
Times Cited: 36







List of co-cited articles
145 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
25

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
Maria E Cabanillas, Mabel Ryder, Camilo Jimenez. Endocr Rev 2019
101
19

Thyroid cancer.
Maria E Cabanillas, David G McFadden, Cosimo Durante. Lancet 2016
617
19

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff,[...]. N Engl J Med 2015
974
16

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Marcia S Brose, Christopher M Nutting, Barbara Jarzab, Rossella Elisei, Salvatore Siena, Lars Bastholt, Christelle de la Fouchardiere, Furio Pacini, Ralf Paschke, Young Kee Shong,[...]. Lancet 2014
858
16

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
16

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
865
11

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.
Vivek Subbiah, Robert J Kreitman, Zev A Wainberg, Jae Yong Cho, Jan H M Schellens, Jean Charles Soria, Patrick Y Wen, Christoph Zielinski, Maria E Cabanillas, Gladys Urbanowitz,[...]. J Clin Oncol 2018
371
11

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
931
11

Thyroid cancer.
Tobias Carling, Robert Udelsman. Annu Rev Med 2014
181
11

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11

Evolving Understanding of the Epidemiology of Thyroid Cancer.
Carolyn Dacey Seib, Julie Ann Sosa. Endocrinol Metab Clin North Am 2019
133
11

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
11

Update on Fundamental Mechanisms of Thyroid Cancer.
Alessandro Prete, Patricia Borges de Souza, Simona Censi, Marina Muzza, Nicole Nucci, Marialuisa Sponziello. Front Endocrinol (Lausanne) 2020
80
11

The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition.
Gilda Varricchi, Stefania Loffredo, Giancarlo Marone, Luca Modestino, Poupak Fallahi, Silvia Martina Ferrari, Amato de Paulis, Alessandro Antonelli, Maria Rosaria Galdiero. Int J Mol Sci 2019
43
8

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
S Filetti, C Durante, D Hartl, S Leboulleux, L D Locati, K Newbold, M G Papotti, A Berruti. Ann Oncol 2019
241
8


Prolonged duration of response in lenvatinib responders with thyroid cancer.
Andrew G Gianoukakis, Corina E Dutcus, Nicolas Batty, Matthew Guo, Mahadi Baig. Endocr Relat Cancer 2018
37
8



Effects and Role of Multikinase Inhibitors in Thyroid Cancer.
Rasmus Laursen, Markus Wehland, Sascha Kopp, Jessica Pietsch, Manfred Infanger, Jirka Grosse, Daniela Grimm. Curr Pharm Des 2016
31
9

The role of SOX family members in solid tumours and metastasis.
Daniela Grimm, Johann Bauer, Petra Wise, Marcus Krüger, Ulf Simonsen, Markus Wehland, Manfred Infanger, Thomas J Corydon. Semin Cancer Biol 2020
138
8

Common Effects on Cancer Cells Exerted by a Random Positioning Machine and a 2D Clinostat.
Benjamin Svejgaard, Markus Wehland, Xiao Ma, Sascha Kopp, Jayashree Sahana, Elisabeth Warnke, Ganna Aleshcheva, Ruth Hemmersbach, Jens Hauslage, Jirka Grosse,[...]. PLoS One 2015
41
8

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
421
8

Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Friedhelm Raue, Karin Frank-Raue. Clin Cancer Res 2016
72
8

Poorly differentiated thyroid cancer.
Kepal N Patel, Ashok R Shaha. Curr Opin Otolaryngol Head Neck Surg 2014
26
11

Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space.
Xiao Ma, Jessica Pietsch, Markus Wehland, Herbert Schulz, Katrin Saar, Norbert Hübner, Johann Bauer, Markus Braun, Achim Schwarzwälder, Jürgen Segerer,[...]. FASEB J 2014
81
8

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
8

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
673
8

Updates on the Management of Thyroid Cancer.
Katherine A Araque, Sriram Gubbi, Joanna Klubo-Gwiezdzinska. Horm Metab Res 2020
30
10

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Christine Dierks, Jochen Seufert, Konrad Aumann, Juri Ruf, Claudius Klein, Selina Kiefer, Michael Rassner, Melanie Boerries, Andreas Zielke, Paul la Rosee,[...]. Thyroid 2021
32
9


PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.
Hashem O Alsaab, Samaresh Sau, Rami Alzhrani, Katyayani Tatiparti, Ketki Bhise, Sushil K Kashaw, Arun K Iyer. Front Pharmacol 2017
786
5


The Diagnosis and Management of Thyroid Nodules: A Review.
Cosimo Durante, Giorgio Grani, Livia Lamartina, Sebastiano Filetti, Susan J Mandel, David S Cooper. JAMA 2018
234
5


Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.
Nigel Fleeman, Rachel Houten, Adrian Bagust, Marty Richardson, Sophie Beale, Angela Boland, Yenal Dundar, Janette Greenhalgh, Juliet Hounsome, Rui Duarte,[...]. Health Technol Assess 2020
16
12

Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.
Elena Tirrò, Federica Martorana, Chiara Romano, Silvia Rita Vitale, Gianmarco Motta, Sandra Di Gregorio, Michele Massimino, Maria Stella Pennisi, Stefania Stella, Adriana Puma,[...]. Genes (Basel) 2019
52
5

Pioglitazone Therapy of PAX8-PPARγ Fusion Protein Thyroid Carcinoma.
Thomas J Giordano, Bryan R Haugen, Steven I Sherman, Manisha H Shah, Elaine M Caoili, Ronald J Koenig. J Clin Endocrinol Metab 2018
15
13

Current thyroid cancer trends in the United States.
Louise Davies, H Gilbert Welch. JAMA Otolaryngol Head Neck Surg 2014
987
5

Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study.
Eun Kyung Lee, Seok-Mo Kim, Bo Hyun Kim, Min Joo Kim, Dong-Jun Lim, Min-Hee Kim, Dong Yeob Shin, Ho-Cheol Kang, Byeong-Cheol Ahn, Sun Wook Kim,[...]. Thyroid 2019
15
13

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
Marcia S Brose, Maria E Cabanillas, Ezra E W Cohen, Lori J Wirth, Todd Riehl, Huibin Yue, Steven I Sherman, Eric J Sherman. Lancet Oncol 2016
182
5

Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data.
M D Aydemirli, E Kapiteijn, K R M Ferrier, P B Ottevanger, T P Links, A N A van der Horst-Schrivers, K E Broekman, R H H Groenwold, J Zwaveling. Eur J Endocrinol 2020
26
7

Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice.
Amandine Berdelou, Isabelle Borget, Yann Godbert, Thierry Nguyen, Marie-Eve Garcia, Cécile N Chougnet, Aurélie Ferru, Camille Buffet, Olivier Chabre, Olivier Huillard,[...]. Thyroid 2018
64
5

Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
Marcia S Brose, Johannes Smit, Chia-Chi Lin, Fabian Pitoia, Marc Fellous, Yoriko DeSanctis, Martin Schlumberger, Masayuki Tori, Iwao Sugitani. Endocr Relat Cancer 2017
24
8

Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practice.
M Molina-Vega, J García-Alemán, A Sebastián-Ochoa, I Mancha-Doblas, J M Trigo-Pérez, F Tinahones-Madueño. Endocrine 2018
17
11

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial.
Maria E Cabanillas, Jonas A de Souza, Susan Geyer, Lori J Wirth, Michael E Menefee, Stephen V Liu, Komal Shah, John Wright, Manisha H Shah. J Clin Oncol 2017
73
5

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
Ezra E W Cohen, Lee S Rosen, Everett E Vokes, Merrill S Kies, Arlene A Forastiere, Francis P Worden, Madeleine A Kane, Eric Sherman, Sinil Kim, Paul Bycott,[...]. J Clin Oncol 2008
463
5

Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program.
Catharina Balmelli, Nikola Railic, Marco Siano, Kristin Feuerlein, Richard Cathomas, Valerie Cristina, Christiane Güthner, Stefan Zimmermann, Sabine Weidner, Miklos Pless,[...]. J Cancer 2018
27
7

Phase II trial of sorafenib in advanced thyroid cancer.
Vandana Gupta-Abramson, Andrea B Troxel, Anoma Nellore, Kanchan Puttaswamy, Maryann Redlinger, Kathy Ransone, Susan J Mandel, Keith T Flaherty, Laurie A Loevner, Peter J O'Dwyer,[...]. J Clin Oncol 2008
499
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.